12:00 AM
 | 
May 06, 2013
 |  BC Week In Review  |  Financial News  |  Amended Offerings

Ambit amends IPO

Ambit Biosciences Corp., San Diego, Calif.
Business: Cancer, Autoimmune, Inflammation
Date announced: 5/2/13
Type: IPO
To be...

Read the full 65 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >